Screener
Gilead Sciences GILD Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
| (in millions) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value |
|---|---|---|---|---|
| U.S. treasury securities | $1,222 | $3 | — | $1,224 |
| U.S. government agencies securities | 15 | — | — | 15 |
| Corporate debt securities | 1,392 | 7 | — | 1,398 |
| Residential mortgage and asset-backed securities | 405 | 2 | — | 407 |
| Total | $3,033 | $11 | $(1) | $3,044 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Gilead Sciences's unrealized losses on investments (before tax)?
- Gilead Sciences (GILD) reported unrealized losses on investments (before tax) of $1M in Q4 2025.
- What does unrealized losses on investments (before tax) mean?
- The total unrealized losses on investments, typically related to available-for-sale securities, before considering tax effects.
Ask your AI about Gilead Sciences's unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude